Displaying drugs 7351 - 7375 of 7786 in total
SD146
Experimental
Matched Synonyms: … 3,3'-{[(4R,5S,6S,7R)-4,7-Dibenzyl-5,6-dihydroxy-2-oxo-1,3-diazepane-1,3-diyl]bis(methylene)}bis[N-(1H-benzimidazol ... -2-yl)benzamide] …
Matched Iupac: … N-(1H-1,3-benzodiazol-2-yl)-3-{[(4R,5S,6S,7R)-3-({3-[(1H-1,3-benzodiazol-2-yl)carbamoyl]phenyl}methyl ... )-4,7-dibenzyl-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}benzamide …
Matched Iupac: … N-(1H-1,3-benzodiazol-2-yl)-3-{[(4R,5S,6S,7R)-3-({3-[(1H-1,3-benzodiazol-2-yl)carbamoyl]phenyl}methyl ... )-4,7-dibenzyl-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl}benzamide …
Benzphetamine
A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)
Approved
Illicit
Matched Synonyms: … N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine …
Matched Iupac: … benzyl(methyl)[(2S)-1-phenylpropan-2-yl]amine …
Matched Description: … (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222) ... A sympathomimetic agent with properties similar to dextroamphetamine. …
Matched Salts cas: … 5411-22-3 …
Matched Categories: … Adrenergic alpha-1 Receptor Agonists ... Cytochrome P-450 Substrates ... Cytochrome P-450 CYP3A Substrates ... Cytochrome P-450 CYP2B6 Substrates ... Cytochrome P-450 CYP3A4 Substrates …
Matched Iupac: … benzyl(methyl)[(2S)-1-phenylpropan-2-yl]amine …
Matched Description: … (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222) ... A sympathomimetic agent with properties similar to dextroamphetamine. …
Matched Salts cas: … 5411-22-3 …
Matched Categories: … Adrenergic alpha-1 Receptor Agonists ... Cytochrome P-450 Substrates ... Cytochrome P-450 CYP3A Substrates ... Cytochrome P-450 CYP2B6 Substrates ... Cytochrome P-450 CYP3A4 Substrates …
N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide
Experimental
Matched Name: … N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide …
Matched Iupac: … N-(3-cyclopropyl-1H-pyrazol-5-yl)benzamide …
Matched Iupac: … N-(3-cyclopropyl-1H-pyrazol-5-yl)benzamide …
1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
Experimental
Matched Name: … 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid …
Matched Iupac: … (2R,3R,4S)-2,4-dihydroxy-3-(sulfooxy)-3,4-dihydro-2H-pyran-6-carboxylic acid …
Matched Iupac: … (2R,3R,4S)-2,4-dihydroxy-3-(sulfooxy)-3,4-dihydro-2H-pyran-6-carboxylic acid …
6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid
Experimental
Matched Name: … 6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid …
Matched Iupac: … 6-(carboxyformamido)-1H-indole-5-carboxylic acid …
Matched Iupac: … 6-(carboxyformamido)-1H-indole-5-carboxylic acid …
5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol
Experimental
Matched Name: … 5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol …
Matched Iupac: … 5-[(1E)-3,3-dihydroxyprop-1-en-1-yl]-3-methoxybenzene-1,2-diol …
Matched Iupac: … 5-[(1E)-3,3-dihydroxyprop-1-en-1-yl]-3-methoxybenzene-1,2-diol …
PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE
Experimental
Matched Name: … PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE …
Matched Iupac: … 2-phenyl-5-(1H-pyrazol-3-yl)-1,3-thiazole …
Matched Iupac: … 2-phenyl-5-(1H-pyrazol-3-yl)-1,3-thiazole …
3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one
Experimental
Matched Name: … 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one …
Matched Iupac: … 3-{[(3S)-3,4-dihydroxybutoxy]amino}-1H,2'H-[2,3'-biindol]-2'-one …
Matched Iupac: … 3-{[(3S)-3,4-dihydroxybutoxy]amino}-1H,2'H-[2,3'-biindol]-2'-one …
Zanidatamab
According to Zymeworks, "ZW25 is a bispecific antibody that can simultaneously bind two non-overlapping epitopes, known as biparatopic binding, of HER2 resulting in dual HER2 signal blockade, increased binding and removal of HER2 protein from the cell surface, and potent effector function. These combined mechanisms of action have led to...
Investigational
Matched Synonyms: … ANTI-HER2 BI-SPECIFIC MONOCLONAL ANTIBODY ZW25 ... KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY, BIPARATOPIC ... IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINEPROTEIN …
Matched Description: … and removal of HER2 protein from the cell surface, and potent effector function. ... combined mechanisms of action have led to significant anti-tumor activity in preclinical models of breast and ... According to Zymeworks, "ZW25 is a bispecific antibody that can simultaneously bind two non-overlapping …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … and removal of HER2 protein from the cell surface, and potent effector function. ... combined mechanisms of action have led to significant anti-tumor activity in preclinical models of breast and ... According to Zymeworks, "ZW25 is a bispecific antibody that can simultaneously bind two non-overlapping …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Cevimeline
Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's syndrome.
Approved
Matched Synonyms: … 2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine …
Matched Iupac: … (2R)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,4]oxathiolane] …
Matched Description: … It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's ... M1 and M3. ... Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors …
Matched Salts cas: … 153504-70-2 …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Drugs that are Mainly Renally Excreted ... Cytochrome P-450 Substrates ... Cytochrome P-450 CYP2D6 Substrates ... Cytochrome P-450 CYP3A Substrates …
Matched Iupac: … (2R)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,4]oxathiolane] …
Matched Description: … It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's ... M1 and M3. ... Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors …
Matched Salts cas: … 153504-70-2 …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Drugs that are Mainly Renally Excreted ... Cytochrome P-450 Substrates ... Cytochrome P-450 CYP2D6 Substrates ... Cytochrome P-450 CYP3A Substrates …
Phenethylamine
Experimental
Matched Synonyms: … 2-phenylethylamine …
Matched Iupac: … 2-phenylethan-1-amine …
Matched Iupac: … 2-phenylethan-1-amine …
Bunamiodyl
Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy.
Withdrawn
Matched Synonyms: … 2-(3-Butyramido-3,4,6-triiodophenylmethylene)butyric acid …
Matched Iupac: … (2E)-2-[(3-butanamido-2,4,6-triiodophenyl)methylidene]butanoic acid …
Matched Description: … Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy. …
Matched Iupac: … (2E)-2-[(3-butanamido-2,4,6-triiodophenyl)methylidene]butanoic acid …
Matched Description: … Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy. …
BBV152
BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or a novel TLR7/8 agonist adsorbed gel....
Investigational
Matched Synonyms: … BBV-152 ... Whole-Virion Inactivated SARS-CoV-2 Vaccine …
Matched Description: … -2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or ... Thus, as of July 2020, BBV152 is in Phase 1/2 clinical trials assessing safety and immunogenicity in ... humans (NCT04471519). …
Matched Categories: … Viral Vaccines …
Matched Description: … -2 strain and a vero cell platform (CCL-81) with adjuncts of either aluminum hydroxide gel (Algel) or ... Thus, as of July 2020, BBV152 is in Phase 1/2 clinical trials assessing safety and immunogenicity in ... humans (NCT04471519). …
Matched Categories: … Viral Vaccines …
(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
Experimental
Matched Name: … (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4- …
Matched Iupac: … (2R,3R,4S,5R)-2-(6-amino-8-{[(3,4-dichlorophenyl)methyl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane …
Matched Iupac: … (2R,3R,4S,5R)-2-(6-amino-8-{[(3,4-dichlorophenyl)methyl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane …
Prednisolone hemisuccinate
Experimental
Matched Synonyms: … Prednisolone 21-succinate ... Prednisolone 21-hemisuccinate …
Matched Iupac: … 4-{2-[(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH ... ,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethoxy}-4-oxobutanoic acid …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Cytochrome P-450 CYP3A Inducers ... Cytochrome P-450 CYP3A4 Inducers ... Cytochrome P-450 CYP3A5 Inducers ... Cytochrome P-450 Enzyme Inducers …
Matched Products: … Prednisolut 100 mg Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung ... Solu-Dacortin 1 g - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung ... Prednisolut 50 mg Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung …
Matched Iupac: … 4-{2-[(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH ... ,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethoxy}-4-oxobutanoic acid …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Cytochrome P-450 CYP3A Inducers ... Cytochrome P-450 CYP3A4 Inducers ... Cytochrome P-450 CYP3A5 Inducers ... Cytochrome P-450 Enzyme Inducers …
Matched Products: … Prednisolut 100 mg Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung ... Solu-Dacortin 1 g - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung ... Prednisolut 50 mg Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung …
2-propenyl-N-acetyl-neuramic acid
Experimental
Matched Name: … 2-propenyl-N-acetyl-neuramic acid …
Matched Iupac: … (2R,4S,5R,6R)-5-acetamido-4-hydroxy-2-(prop-2-en-1-yl)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic …
Matched Iupac: … (2R,4S,5R,6R)-5-acetamido-4-hydroxy-2-(prop-2-en-1-yl)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic …
(R)-2-Hydroxy-3-Sulfopropanoic Acid
Experimental
Matched Name: … (R)-2-Hydroxy-3-Sulfopropanoic Acid …
Matched Iupac: … (2R)-2-hydroxy-3-sulfopropanoic acid …
Matched Iupac: … (2R)-2-hydroxy-3-sulfopropanoic acid …
N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine
Experimental
Matched Name: … N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine …
Matched Iupac: … (2S)-2-[(2S)-3-phenyl-2-[(2R)-3-phenyl-2-sulfanylpropanamido]propanamido]propanoic acid …
Matched Iupac: … (2S)-2-[(2S)-3-phenyl-2-[(2R)-3-phenyl-2-sulfanylpropanamido]propanamido]propanoic acid …
2',6'-Dichloro-Biphenyl-2,6-Diol
Experimental
Matched Name: … 2',6'-Dichloro-Biphenyl-2,6-Diol …
Matched Iupac: … 2',6'-dichloro-[1,1'-biphenyl]-2,3-diol …
Matched Iupac: … 2',6'-dichloro-[1,1'-biphenyl]-2,3-diol …
3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid
Experimental
Matched Name: … 3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid …
Matched Iupac: … 3-(phosphonomethyl)pyridine-2-carboxylic acid …
Matched Iupac: … 3-(phosphonomethyl)pyridine-2-carboxylic acid …
2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID
Experimental
Matched Name: … 2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID …
Matched Iupac: … (2R)-2-{3-[(diaminomethylidene)amino]phenyl}-3-sulfanylpropanoic acid …
Matched Iupac: … (2R)-2-{3-[(diaminomethylidene)amino]phenyl}-3-sulfanylpropanoic acid …
TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE
Experimental
Matched Name: … TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE …
Matched Iupac: … (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidin-1-ium-1-olate …
Matched Iupac: … (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidin-1-ium-1-olate …
2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE
Experimental
Matched Name: … 2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE …
Matched Iupac: … 2-amino-6-(3,5-dimethylbenzenesulfonyl)benzonitrile …
Matched Iupac: … 2-amino-6-(3,5-dimethylbenzenesulfonyl)benzonitrile …
Polyquaternium-10 (400 cps at 2%)
Polyquaternium-10 is a quaternized hydroxyethyl cellulose and a polycationic polymer. It is commonly found in cosmetics and personal care products to mainly reduce static electricity and form films.
Approved
Matched Name: … Polyquaternium-10 (400 cps at 2%) …
Matched Description: … Polyquaternium-10 is a quaternized hydroxyethyl cellulose and a polycationic polymer. ... It is commonly found in cosmetics and personal care products to mainly reduce static electricity and …
Matched Description: … Polyquaternium-10 is a quaternized hydroxyethyl cellulose and a polycationic polymer. ... It is commonly found in cosmetics and personal care products to mainly reduce static electricity and …
Anti-SARS-CoV-2 REGN-COV2
Anti-SARS-COV-2 REGN-COV2 is a combination of novel antibodies designed by Regeneron for both the prevention and treatment of SARS-COV-2, the virus that causes COVID-19. This drug is a combination of the antibodies REGN10933 and REGN10987, derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered...
Investigational
Matched Name: … Anti-SARS-CoV-2 REGN-COV2 …
Matched Description: … and treatment of SARS-COV-2, the virus that causes COVID-19. ... Anti-SARS-COV-2 REGN-COV2 is a combination of novel antibodies designed by Regeneron for both the prevention ... COVID-19 patients (non-hospitalized), and uninfected individuals at high-risk of infection, including …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Experimental Unapproved Treatments for COVID-19 …
Matched Description: … and treatment of SARS-COV-2, the virus that causes COVID-19. ... Anti-SARS-COV-2 REGN-COV2 is a combination of novel antibodies designed by Regeneron for both the prevention ... COVID-19 patients (non-hospitalized), and uninfected individuals at high-risk of infection, including …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Experimental Unapproved Treatments for COVID-19 …
Displaying drugs 7351 - 7375 of 7786 in total